Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 12

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

Research Network

Collaboration Network

25 collaborators·26 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Thomas Marbury, MD

Orlando Clinical Research Center

Moderately Similar
11 trials

Shared therapeutic areas:

Healthy VolunteersPharmacokineticsPatients+1 more

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score44%

Aslak Rautio, MD

Quintiles Hermelinen

Related
2 trials

Shared therapeutic areas:

Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.Healthy Volunteers

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score24%

Wolfgang Kuhn, MD

Quintiles Phase 1

Related
1 trials

Shared therapeutic areas:

Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.

Worked with same sponsors:

AstraZeneca
Collaborated on 1 trial
Similarity Score14%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

Related
35 trials

Shared therapeutic areas:

Healthy VolunteersPharmacokinetics
Similarity Score12%

Tage Ramakrishna, MD

Progenics Pharmaceuticals, Inc.

Related
19 trials

Shared therapeutic areas:

Healthy VolunteersRenal Impairment
Similarity Score12%

Paolo Bonato, PhD

Spaulding Rehabilitation Hospital

Related
19 trials

Shared therapeutic areas:

Healthy Volunteers
Similarity Score6%

Herbert B Slade, MD

Healthpoint

Related
18 trials

Shared therapeutic areas:

Healthy Volunteers
Similarity Score6%

Pablo Tebas, MD

University of Pennsylvania

Related
14 trials

Shared therapeutic areas:

Healthy Volunteers

Worked with same sponsors:

AstraZeneca
Similarity Score6%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Healthy Volunteers
Similarity Score6%

James C Eisenach, MD

Wake Forest University Health Sciences

Related
18 trials

Shared therapeutic areas:

Healthy Volunteers
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT01239771Phase 1StudyDirector

A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects

Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.
Completed
NCT01240967Phase 1StudyDirector

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

Healthy VolunteersPatientsPharmacokinetics+1 more
Completed

All 2 trials loaded